The short answer — and why it depends

For many patients with a focal cartilage injury, the answer is a conditional yes — and the condition matters enormously. Long-term data from matrix-induced chondrocyte implantation show that roughly 9 in 10 appropriately selected patients avoid knee replacement over a decade of follow-up. The operative word is 'appropriately selected.'

Cartilage repair works when there is an isolated, focal defect — typically the result of an injury — in a knee that is otherwise well-aligned, stable, and free of widespread degenerative change. It offers little or no benefit when the problem is diffuse bone-on-bone osteoarthritis, severe joint malalignment, or meniscal deficiency. In those situations, repair tissue has neither the mechanical environment nor the biological conditions to survive.

One important distinction for patients researching their options: simple arthroscopic washout or debridement — a common historical procedure — has no evidence of delaying or avoiding knee replacement. It is not a form of biologic restoration and should not be confused with genuine cartilage repair.

The evidence that underpins these conclusions, and what it means for different defect types and patient profiles, is set out in the sections that follow.

What the 10-year evidence actually shows

Two cohort studies — one of 168 patients, one of 204 — tracked MACI recipients for a minimum of ten years and produced strikingly consistent findings. TKA conversion rates sat at 7.4% and 9.3% respectively, confirming that the large majority of patients remained replacement-free across the full follow-up period.

Patient satisfaction figures reinforce that picture: 92% reported satisfaction with pain relief at ten years in the prospective cohort. Patient-reported outcome scores — covering pain, function, and quality of life — improved significantly within the first two years and held stable through the decade without meaningful decline. The durability of those gains rules out a short-lived honeymoon effect; the clinical benefit endures long-term. MRI at ten-year follow-up confirmed satisfactory cartilage graft integration in the majority of cases, providing structural corroboration for what patients were reporting clinically.

One caveat sits squarely alongside these results. The mean patient age in the larger systematic review was 37 years. These were predominantly younger patients with traumatic focal defects — not the 50- or 55-year-old with a longer history of progressive joint changes. Whether outcomes translate comparably to middle-aged patients remains uncertain; the studies were not designed to answer that question, and extrapolation should be made cautiously.

The deeper evidential gap is at population level: no large randomised trial has yet assigned patients aged 45–60 to either early cartilage repair or early knee replacement to compare outcomes directly. The long-term cohort data are robust within their patient profile, but that specific comparative question remains open.

Matching the technique to the defect

Defect size provides the most practical starting point for understanding why surgeons do not reach for the same operation every time.

Smaller defects (roughly under 2–4 cm²)

For contained focal lesions at the smaller end of the spectrum, osteochondral autograft transfer — OATS or mosaicplasty — transplants a plug of the patient's own bone and cartilage directly into the defect in a single procedure. It is well-supported for lesions in the 1–2 cm² range, though donor-site discomfort from the harvest site is a meaningful consideration that should be discussed at consultation. Microfracture has historically occupied this size band too, but its role is declining: the repair tissue it generates is fibrocartilage rather than hyaline cartilage, and published evidence shows this tissue tends to degrade within two to three years, limiting its durability as a long-term solution.

Larger defects (3 cm² and above)

For lesions at this size, MACI has the strongest evidence base. The SUMMIT trial demonstrated significantly improved KOOS pain and function scores with MACI compared to microfracture at both two and five years, establishing it as the preferred option for larger focal lesions. Where the two-stage cell-culture process that MACI requires is not practical — it involves a biopsy followed by a separate implantation procedure — AMIC (matrix-augmented microfracture, a single-stage alternative) and minced cartilage implantation are viable options. A matched comparison of 48 patients across all three techniques found equivalent improvements in pain and function scores at two years, though longer-term comparative data beyond that point remain limited.

When a first repair fails

The pathway does not close if an initial procedure does not succeed. Fresh osteochondral allograft (OCA) and focal metallic resurfacing — which recorded a 97.7% four-year survival in a 132-patient series — serve as validated intermediate steps that keep knee replacement available as a future option if needed.

Defect size thresholds are a guide rather than a rule. Lesion depth, bone involvement, anatomical location, and the surgeon's experience all influence the final choice.

Who is — and is not — a candidate

Candidacy hinges on the nature of the damage as much as on the patient's age — and the distinction is more nuanced than a single number on a birth certificate.

Factors that point towards cartilage repair

• A traumatic, focal defect — typically a discrete lesion with healthy surrounding cartilage rather than generalised wear
• Biological age and activity level that support tissue healing; a fit, active 52-year-old with one focal lesion may be a stronger candidate than a sedentary 45-year-old with diffuse joint changes
• A knee that is well-aligned, ligamentously stable, and has intact or adequately reconstructed menisci
• No significant bone loss at the base of the defect

Factors that erode or eliminate benefit

If the damage is widespread across multiple compartments, if bone-on-bone contact is already established, or if meniscal deficiency has never been addressed, cartilage repair is unlikely to produce durable relief. In these circumstances the clinical conversation shifts — typically towards palliative management or joint replacement — and that is not a failure of the process; it is an honest application of the evidence.

When malalignment is the obstacle

Uncorrected varus or valgus deformity concentrates mechanical load directly onto the repair site, undermining any biological restoration. This does not automatically mean a patient is excluded. A realignment procedure — high tibial osteotomy (HTO) or distal femoral osteotomy (DFO) — can redistribute load away from the damaged compartment and is sometimes performed alongside or before cartilage repair to restore the mechanical environment the graft needs to survive.

Confirming candidacy involves staging the lesion on MRI and assessing how load is distributed across the joint — findings that shape the choice of procedure and its realistic prognosis.

If repair eventually fails — does it compromise a future knee replacement?

One of the most common anxieties patients raise in consultation is whether attempting cartilage repair might somehow 'use up' the knee replacement option or leave them worse off if the repair eventually fails. The evidence gives a clear and reassuring answer.

A matched cohort study followed 43 patients who had undergone cartilage surgery — ACI, osteochondral allograft, or microfracture — and ultimately went on to total knee arthroplasty. Compared with 129 matched patients who had proceeded directly to TKA, there were no significant differences in post-operative KOOS-JR scores (69.8 versus 69.9), 90-day readmission rates, or revision rates. The technical complexity of the replacement procedure was not increased, and functional recovery was equivalent. Prior cartilage surgery, in other words, does not burn bridges.

Equally notable is what the interval between procedures represents. The mean time from index cartilage surgery to TKA conversion in that cohort was 4.6 years — years spent in the native joint, with improved function and reduced pain, rather than years lost to a failed gamble.

That context reframes the clinical decision in a way that many patients find genuinely useful. The choice is not, as it is sometimes framed, between cartilage repair and knee replacement. It is a question of whether to attempt joint preservation now — with TKA remaining fully available as a reliable backstop — or to proceed directly to replacement. For appropriately selected patients, the evidence suggests that trying first carries no penalty if it eventually falls short.

Getting an evidence-based assessment

All of the evidence reviewed here applies at the population level. Whether it applies to a specific knee depends on factors that imaging and clinical assessment must establish: the grade and size of the lesion, the mechanical axis of the limb, the condition of the surrounding cartilage and menisci, and the patient's biological capacity to heal. Without that staging, the question of whether cartilage repair can delay or prevent a knee replacement cannot honestly be answered.

For patients in the East Midlands and wider non-London catchment, MSK Doctors consultants see patients at Sleaford, Lincolnshire and at Grantham — both with on-site MRI — without requiring a GP referral. London-based readers can access equivalent specialist input through the London Cartilage Clinic. In either setting, the starting point is the same structured evaluation: lesion staging, alignment assessment, and a clear-eyed conversation about whether the goal is tissue restoration, load redistribution, or a planned combination of both.

Appointments can be booked directly at mskdoctors.com.

1. [1] Minimum 10-Year Outcomes of Matrix-Induced Autologous Chondrocyte Implantation in the Knee. (2024). https://doi.org/10.1177/03635465231205309 https://doi.org/10.1177/03635465231205309
2. [2] 10-Year Prospective Clinical and Radiological Evaluation After Matrix-Induced Autologous Chondrocyte Implantation. (2024). https://doi.org/10.1177/03635465241227969 https://doi.org/10.1177/03635465241227969
3. [3] Focal articular surface replacement of knee lesions after failed cartilage repair using focal metallic implants: 132 cases, 4-year follow-up. (2021). https://doi.org/10.1016/j.knee.2021.01.014 https://doi.org/10.1016/j.knee.2021.01.014
4. [4] Autologous bone grafting combined with spheroid-based MACI for osteochondral defects of the knee. (2025). https://doi.org/10.1002/ksa.12605 https://doi.org/10.1002/ksa.12605
5. [5] Comparison of MACI vs AMIC vs Arthroscopic Minced Cartilage — 2-Year Follow-Up. (2025). https://doi.org/10.3390/jcm14072194 https://doi.org/10.3390/jcm14072194
6. [6] Undergoing cartilage procedures before total knee arthroplasty is not associated with worse postoperative functional outcomes, readmission rates or complication rates. (2024). https://doi.org/10.1002/ksa.12529 https://doi.org/10.1002/ksa.12529